Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer
Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer
复制标题
DOI:
10.1016/s0090-4295(01)00940-2
复制
发表时间:
2001-05-01
期刊:
影响因子:
2.1
通讯作者:
Roach, M
中科院分区:
文献类型:
--
作者:
Fisch, BM;Pickett, B;Roach, M
Objectives. To evaluate the effect of the dose to the bulb of the penis on postradiation potency.Methods. Twenty-one patients reporting potency before three-dimensional conformal radiotherapy had the dose delivered to the bulb of the penis evaluated. This was then compared with the patient assessments of post-treatment sexual function to determine whether a dose-volume relationship exists.Results. Among the patients analyzed to date, a strong dose-volume relationship and the likelihood of remaining potent after treatment seems to exist. Patients receiving a dose of less than 40 Gy to 70% of the bulb of the penis appear to have a much greater likelihood of maintaining potency. Patients receiving 70 Gy or more to 70% of the bulb of the penis appear to be at very high risk of experiencing radiation-induced impotence (P = 0.03).Conclusions. More studies are needed to confirm these observations. If confirmed, these data suggest that by using three-dimensional-based treatment planning and carefully designed treatment fields, the potency of men treated with radiotherapy might be substantially improved. UROLOGY 57: 955-959, 2001. (C) 2001, Elsevier Science Inc.